Loading...
XASE
DSS
Market cap9mUSD
Dec 05, Last price  
1.04USD
1D
3.82%
1Q
-16.94%
Jan 2017
-99.74%
Name

Dss Inc

Chart & Performance

D1W1MN
XASE:DSS chart
P/E
P/S
0.49
EPS
Div Yield, %
Shrs. gr., 5y
65.45%
Rev. gr., 5y
-0.32%
Revenues
19m
-36.89%
1,749,8644,834,4245,991,1966,643,0079,911,69113,381,58113,383,60417,115,00017,453,00018,287,00017,505,00019,177,00018,662,00018,515,08219,409,23017,411,00020,275,00047,307,00030,258,00019,097,000
Net income
-47m
L-41.82%
-2,842,790-4,832,366-6,986,830-8,285,142-3,990,013-4,603,890-3,222,146-4,281,0002,594,000-41,157,000-14,309,000-950,000-578,0001,464,969-2,889,1473,086,000-34,050,000-69,662,000-80,606,000-46,896,000
CFO
-9m
L-52.68%
-1,689,721-1,411,677-3,219,322-2,390,771-1,595,101-1,759,253-2,124,505-3,163,283-3,149,239-2,390,238-976,6305,466,525-1,367,530-1,382,921-5,342,874-6,152,000-8,805,000-26,953,000-19,194,000-9,082,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged in—nonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
IPO date
Oct 27, 1993
Employees
119
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT